BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 29326019)

  • 1. Isolation of a peptide containing d-amino acid residues that inhibits the α-helix-mediated p53-MDM2 interaction from a one-bead one-compound library.
    Morimoto J; Hosono Y; Sando S
    Bioorg Med Chem Lett; 2018 Feb; 28(3):231-234. PubMed ID: 29326019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive peptidomimetic libraries targeting protein-protein interactions.
    Whitby LR; Boger DL
    Acc Chem Res; 2012 Oct; 45(10):1698-709. PubMed ID: 22799570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo designed library of linear helical peptides: an exploratory tool in the discovery of protein-protein interaction modulators.
    Bonache MÁ; Balsera B; López-Méndez B; Millet O; Brancaccio D; Gómez-Monterrey I; Carotenuto A; Pavone LM; Reille-Seroussi M; Gagey-Eilstein N; Vidal M; de la Torre-Martinez R; Fernández-Carvajal A; Ferrer-Montiel A; García-López MT; Martín-Martínez M; de Vega MJ; González-Muñiz R
    ACS Comb Sci; 2014 May; 16(5):250-8. PubMed ID: 24725184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporation of Putative Helix-Breaking Amino Acids in the Design of Novel Stapled Peptides: Exploring Biophysical and Cellular Permeability Properties.
    Partridge AW; Kaan HYK; Juang YC; Sadruddin A; Lim S; Brown CJ; Ng S; Thean D; Ferrer F; Johannes C; Yuen TY; Kannan S; Aronica P; Tan YS; Pradhan MR; Verma CS; Hochman J; Chen S; Wan H; Ha S; Sherborne B; Lane DP; Sawyer TK
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31226791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suprastapled Peptides: Hybridization-Enhanced Peptide Ligation and Enforced α-Helical Conformation for Affinity Selection of Combinatorial Libraries.
    Sabale PM; Imiołek M; Raia P; Barluenga S; Winssinger N
    J Am Chem Soc; 2021 Nov; 143(45):18932-18940. PubMed ID: 34739233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α-Helix-Mimicking Sulfono-γ-AApeptide Inhibitors for p53-MDM2/MDMX Protein-Protein Interactions.
    Sang P; Shi Y; Lu J; Chen L; Yang L; Borcherds W; Abdulkadir S; Li Q; Daughdrill G; Chen J; Cai J
    J Med Chem; 2020 Feb; 63(3):975-986. PubMed ID: 31971801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of a novel MDM2 binding peptide based on the p53 family.
    Madhumalar A; Lee HJ; Brown CJ; Lane D; Verma C
    Cell Cycle; 2009 Sep; 8(17):2828-36. PubMed ID: 19713735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Cyclized Helix-Loop-Helix Peptide as a Molecular Scaffold for the Design of Inhibitors of Intracellular Protein-Protein Interactions by Epitope and Arginine Grafting.
    Fujiwara D; Kitada H; Oguri M; Nishihara T; Michigami M; Shiraishi K; Yuba E; Nakase I; Im H; Cho S; Joung JY; Kodama S; Kono K; Ham S; Fujii I
    Angew Chem Int Ed Engl; 2016 Aug; 55(36):10612-5. PubMed ID: 27467415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Effective Virtual Screening Protocol To Identify Promising p53-MDM2 Inhibitors.
    Tortorella P; Laghezza A; Durante M; Gomez-Monterrey I; Bertamino A; Campiglia P; Loiodice F; Daniele S; Martini C; Agamennone M
    J Chem Inf Model; 2016 Jun; 56(6):1216-27. PubMed ID: 27269808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elaboration of Non-naturally Occurring Helical Tripeptides as p53-MDM2/MDMX Interaction Inhibitors.
    Su A; Tabata Y; Aoki K; Sada A; Ohki R; Nagatoishi S; Tsumoto K; Wang S; Otani Y; Ohwada T
    Chem Pharm Bull (Tokyo); 2021 Jul; 69(7):681-692. PubMed ID: 33952867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for the conserved binding mechanism of MDM2-inhibiting peptides and anti-apoptotic Bcl-2 family proteins.
    Lee MS; Ha JH; Yoon HS; Lee CK; Chi SW
    Biochem Biophys Res Commun; 2014 Feb; 445(1):120-5. PubMed ID: 24491548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell Membrane Composition Drives Selectivity and Toxicity of Designed Cyclic Helix-Loop-Helix Peptides with Cell Penetrating and Tumor Suppressor Properties.
    Philippe GJ; Gaspar D; Sheng C; Huang YH; Benfield AH; Condon ND; Weidmann J; Lawrence N; Löwer A; Castanho MARB; Craik DJ; Troeira Henriques S
    ACS Chem Biol; 2019 Sep; 14(9):2071-2087. PubMed ID: 31390185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. d-Amino acid mutation of PMI as potent dual peptide inhibitors of p53-MDM2/MDMX interactions.
    Li X; Liu C; Chen S; Hu H; Su J; Zou Y
    Bioorg Med Chem Lett; 2017 Oct; 27(20):4678-4681. PubMed ID: 28916339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helix stabilized, thermostable, and protease-resistant self-assembled peptide nanostructures as potential inhibitors of protein-protein interactions.
    Jeong WJ; Lee MS; Lim YB
    Biomacromolecules; 2013 Aug; 14(8):2684-9. PubMed ID: 23844716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural details on mdm2-p53 interaction.
    Chi SW; Lee SH; Kim DH; Ahn MJ; Kim JS; Woo JY; Torizawa T; Kainosho M; Han KH
    J Biol Chem; 2005 Nov; 280(46):38795-802. PubMed ID: 16159876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational Design of Right-Handed Heterogeneous Peptidomimetics as Inhibitors of Protein-Protein Interactions.
    Shi Y; Sang P; Lu J; Higbee P; Chen L; Yang L; Odom T; Daughdrill G; Chen J; Cai J
    J Med Chem; 2020 Nov; 63(21):13187-13196. PubMed ID: 33140956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. hDM2 protein-binding peptides screened from stapled α-helical peptide phage display libraries with different types of staple linkers.
    Anananuchatkul T; Tsutsumi H; Miki T; Mihara H
    Bioorg Med Chem Lett; 2020 Dec; 30(23):127605. PubMed ID: 33038548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis and Evaluation of 2,5-Diketopiperazines as Inhibitors of the MDM2-p53 Interaction.
    Pettersson M; Quant M; Min J; Iconaru L; Kriwacki RW; Waddell MB; Guy RK; Luthman K; Grøtli M
    PLoS One; 2015; 10(10):e0137867. PubMed ID: 26427060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of specificity of MDM2 for the activation domains of p53 and p65: proline27 disrupts the MDM2-binding motif of p53.
    Zondlo SC; Lee AE; Zondlo NJ
    Biochemistry; 2006 Oct; 45(39):11945-57. PubMed ID: 17002294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Miniature protein inhibitors of the p53-hDM2 interaction.
    Kritzer JA; Zutshi R; Cheah M; Ran FA; Webman R; Wongjirad TM; Schepartz A
    Chembiochem; 2006 Jan; 7(1):29-31. PubMed ID: 16397877
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.